Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 19-Nov-24 8:03 PM View:  | Haley Patrick J. EVP, Commercial | Exelixis, Inc. (EXEL) | 18-Nov-24 | Sale | 19,381 | $34.41 | $666,900.00 | (5%) 364.44K to 345.06K | |
| 19-Nov-24 8:03 PM View: | Haley Patrick J. EVP, Commercial | Exelixis, Inc. (EXEL) | 18-Nov-24 | Sale (Planned) | 22,207 | $34.31 | $761,922.00 | (6%) 345.06K to 322.85K | |
| 19-Nov-24 8:03 PM View: | Hessekiel Jeffrey EVP & General Counsel | Exelixis, Inc. (EXEL) | 15-Nov-24 | Payment of Exercise | 14,672 | $35.05 | $514,254.00 | (3%) 531.32K to 516.65K | |
| 19-Nov-24 8:03 PM View: | Morrissey Michael M President and CEO Director | Exelixis, Inc. (EXEL) | 15-Nov-24 | Payment of Exercise | 47,642 | $35.05 | $1,669,850.00 | (2%) 2.39M to 2.34M | |
| 19-Nov-24 8:03 PM View: | Haley Patrick J. EVP, Commercial | Exelixis, Inc. (EXEL) | 15-Nov-24 | Payment of Exercise | 14,672 | $35.05 | $514,254.00 | (4%) 379.11K to 364.44K | |
| 19-Nov-24 8:03 PM View: | Senner Christopher J. EVP and CFO | Exelixis, Inc. (EXEL) | 15-Nov-24 | Payment of Exercise | 17,506 | $35.05 | $613,585.00 | (2%) 724.4K to 706.9K | |
| 19-Nov-24 8:02 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 15-Nov-24 | Payment of Exercise | 12,838 | $35.05 | $449,972.00 | (3%) 504.78K to 491.94K | |
| 25-Sep-24 7:32 PM View: | Hessekiel Jeffrey EVP & General Counsel | Exelixis, Inc. (EXEL) | 23-Sep-24 | Private Sale (Planned) | 25,000 | $26.38 | $659,500.00 | (4%) 631.32K to 606.32K | |
| 28-Aug-24 7:07 PM View: | Hessekiel Jeffrey EVP, General Counsel & Sec | Exelixis, Inc. (EXEL) | 26-Aug-24 | Option Exercise | 20,000 | $24.41 | $488,200.00 | 3% 631.32K to 651.32K | |
| 28-Aug-24 7:07 PM View: | Hessekiel Jeffrey EVP, General Counsel & Sec | Exelixis, Inc. (EXEL) | 26-Aug-24 | Planned Option Sale | 20,000 | $25.79 | $515,800.00 | (3%) 651.32K to 631.32K | |
| 16-Aug-24 7:35 PM View: | Freire Maria C Director | Exelixis, Inc. (EXEL) | 14-Aug-24 | Private Sale | 8,250 | $26.56 | $219,120.00 | (8%) 99.26K to 91.01K | |
| 15-Aug-24 8:18 PM View: | Smith Julie Director | Exelixis, Inc. (EXEL) | 13-Aug-24 | Disposition (other) | 4,682 | -- | -- | (30%) 15.46K to 10.78K | |
| 14-Aug-24 7:12 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 12-Aug-24 | Private Sale | 20,883 | $27.06 | $565,094.00 | (4%) 526.83K to 505.94K | |
| 09-Aug-24 7:31 PM View: | Senner Christopher J. EVP and CFO | Exelixis, Inc. (EXEL) | 09-Aug-24 | Option Exercise | 125,000 | $24.41 | $3,051,250.00 | 17% 724.4K to 849.4K | |
| 09-Aug-24 7:31 PM View: | Senner Christopher J. EVP and CFO | Exelixis, Inc. (EXEL) | 09-Aug-24 | Option Sale | 125,000 | $27.19 | $3,398,750.00 | (15%) 849.4K to 724.4K | |
| 12-Aug-24 7:22 PM View: | Poste George Director | Exelixis, Inc. (EXEL) | 08-Aug-24 | Private Sale | 33,725 | $26.89 | $906,865.00 | (14%) 232.75K to 199.02K | |
| 09-Aug-24 7:32 PM View: | Hessekiel Jeffrey EVP, General Counsel & Sec | Exelixis, Inc. (EXEL) | 07-Aug-24 | Planned Option Sale | 80,000 | $25.97 | $2,077,600.00 | (11%) 711.32K to 631.32K | |
| 09-Aug-24 7:32 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 07-Aug-24 | Planned Option Sale | 95,000 | $25.00 | $2,375,000.00 | (15%) 621.83K to 526.83K | |
| 09-Aug-24 7:32 PM View: | Haley Patrick J. EVP, Commercial | Exelixis, Inc. (EXEL) | 07-Aug-24 | Private Sale (Planned) | 14,000 | $25.50 | $357,000.00 | (4%) 389.22K to 375.22K | |
| 09-Aug-24 7:32 PM View: | Hessekiel Jeffrey EVP, General Counsel & Sec | Exelixis, Inc. (EXEL) | 07-Aug-24 | Option Exercise | 80,000 | $24.41 | $1,952,800.00 | 13% 631.32K to 711.32K | |
| 09-Aug-24 7:32 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 07-Aug-24 | Option Exercise | 95,000 | $24.41 | $2,318,950.00 | 18% 526.83K to 621.83K | |
| 06-Jun-24 8:37 PM View: | Wyszomierski Jack L Director | Exelixis, Inc. (EXEL) | 04-Jun-24 | Private Sale (Planned) | 8,287 | $22.00 | $182,314.00 | (2%) 357.79K to 349.5K | |
| 04-Jun-24 8:20 PM View: | Oliver Bob Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 104% 18.18K to 37.01K | |
| 04-Jun-24 8:19 PM View: | Eckhardt Sue Gail Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 122% 15.42K to 34.26K | |
| 04-Jun-24 8:21 PM View: | Poste George Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 9% 213.91K to 232.75K | |
| 04-Jun-24 8:21 PM View: | Papadopoulos Stelios Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 1% 1.26M to 1.28M | |
| 04-Jun-24 8:20 PM View: | Heyman Tomas J. Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 104% 18.18K to 37.01K | |
| 04-Jun-24 8:19 PM View: | Beckerle Mary C Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 122% 15.42K to 34.26K | |
| 04-Jun-24 8:20 PM View: | Freire Maria C Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 23% 80.42K to 99.26K | |
| 04-Jun-24 8:19 PM View: | Smith Julie Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 10,015 | -- | -- | 184% 5.45K to 15.46K | |
| 04-Jun-24 8:20 PM View: | Wyszomierski Jack L Director | Exelixis, Inc. (EXEL) | 31-May-24 | Grant | 18,838 | -- | -- | 6% 338.95K to 357.79K | |
| 30-May-24 7:50 PM View: | Johnson David Edward Director | Exelixis, Inc. (EXEL) | 30-May-24 | Purchase | 225,000 | $20.76 | $4,670,060.00 | 17% 1.32M to 1.54M | |
| 30-May-24 7:50 PM View: | Johnson David Edward Director | Exelixis, Inc. (EXEL) | 28-May-24 | Purchase | 200,000 | $20.32 | $4,063,900.00 | 18% 1.12M to 1.32M | |
| 22-May-24 7:23 PM View: | Poste George Director | Exelixis, Inc. (EXEL) | 21-May-24 | Private Option Sale | 11,686 | $20.96 | $244,939.00 | (5%) 225.59K to 213.91K | |
| 23-May-24 10:00 PM View: | Smith Julie Director | Exelixis, Inc. (EXEL) | 21-May-24 | Private Sale | 27,280 | $21.12 | $576,154.00 | (83%) 32.73K to 5.45K | |
| 22-May-24 7:23 PM View: | Poste George Director | Exelixis, Inc. (EXEL) | 21-May-24 | Option Exercise | 11,686 | $19.57 | $228,695.00 | 5% 213.91K to 225.59K | (7%) |
| 22-May-24 7:23 PM View: | Papadopoulos Stelios Director | Exelixis, Inc. (EXEL) | 20-May-24 | Private Option Sale | 11,437 | $21.00 | $240,177.00 | (< 1%) 1.27M to 1.26M | |
| 22-May-24 7:23 PM View: | Papadopoulos Stelios Director | Exelixis, Inc. (EXEL) | 20-May-24 | Option Exercise | 11,686 | $19.57 | $228,695.00 | < 1% 1.26M to 1.27M | (7%) |
| 17-May-24 7:58 PM View: | Haley Patrick J. EVP, Commercial | Exelixis, Inc. (EXEL) | 15-May-24 | Payment of Exercise | 31,044 | $20.99 | $651,614.00 | (7%) 420.27K to 389.22K | |
| 17-May-24 7:57 PM View: | Hessekiel Jeffrey EVP, General Counsel & Sec | Exelixis, Inc. (EXEL) | 15-May-24 | Payment of Exercise | 25,941 | $20.99 | $544,502.00 | (4%) 657.26K to 631.32K | |
| 17-May-24 7:58 PM View: | Morrissey Michael M President and CEO Director | Exelixis, Inc. (EXEL) | 15-May-24 | Payment of Exercise | 73,943 | $20.99 | $1,552,060.00 | (3%) 2.49M to 2.42M | |
| 17-May-24 7:58 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 15-May-24 | Payment of Exercise | 22,605 | $20.99 | $474,479.00 | (4%) 549.43K to 526.83K | |
| 17-May-24 7:57 PM View: | Senner Christopher J. EVP and CFO | Exelixis, Inc. (EXEL) | 15-May-24 | Payment of Exercise | 30,310 | $20.99 | $636,207.00 | (4%) 754.71K to 724.4K | |
| 15-May-24 7:44 PM View: | Wyszomierski Jack L Director | Exelixis, Inc. (EXEL) | 13-May-24 | Option Exercise | 11,686 | $19.57 | $228,695.00 | 3% 338.19K to 349.87K | (7%) |
| 15-May-24 7:44 PM View: | Wyszomierski Jack L Director | Exelixis, Inc. (EXEL) | 13-May-24 | Planned Private Option Sale | 10,923 | $21.37 | $233,425.00 | (3%) 349.87K to 338.95K | |
| 25-Mar-24 7:31 PM View: | Garber Alan M Director | Exelixis, Inc. (EXEL) | 21-Mar-24 | Planned Private Option Sale | 19,205 | $24.01 | $461,112.00 | (35%) 54.91K to 35.7K | |
| 25-Mar-24 7:31 PM View: | Garber Alan M Director | Exelixis, Inc. (EXEL) | 21-Mar-24 | Option Exercise | 23,491 | $19.57 | $459,719.00 | 75% 31.42K to 54.91K | (7%) |
| 27-Feb-24 6:59 PM View: | Peterson Amy C. EVP Prod Dev & Med Aff & CMO | Exelixis, Inc. (EXEL) | 23-Feb-24 | Grant | 82,121 | -- | -- | 34% 240.0K to 322.12K | |
| 27-Feb-24 6:58 PM View: | Senner Christopher J. EVP and CFO | Exelixis, Inc. (EXEL) | 23-Feb-24 | Grant | 82,121 | -- | -- | 12% 672.59K to 754.71K | |
| 27-Feb-24 6:58 PM View: | Aftab Dana CSO/EVP Disc & Trans Research | Exelixis, Inc. (EXEL) | 23-Feb-24 | Grant | 63,350 | -- | -- | 13% 484.87K to 548.22K |
